Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies

Alternate Title: Análisis de minimización de costes de la leucemia linfocítica crónica en España en la era de las terapias orales dirigidas (Spanish; Castilian)

Authors: Montañés, Belén ^*, Casado, Gema, Medina, Ángeles, Nieto, Pablo, Ramírez-Payer, Ángel

Source: In Farmacia Hospitalaria March-April 2022 46(2):72-79

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Authors: Abrisqueta, Pau, Loscertales, Javier, Terol, Maria José, Ramírez Payer, Ángel, Ortiz, Macarena, Pérez, Inmaculada, Cuellar-García, Carolina, Fernández de la Mata, Margarita, Rodríguez, Alicia, Lario, Ana, Delgado, Julio, Godoy, Ana, Arguiñano Pérez, José Mª, Berruezo, Mª José, Oliveira, Ana, Hernández-Rivas, José-Ángel, García Malo, Maria Dolores, Medina, Ángeles, García Martin, Paloma, Osorio, Santiago, Baltasar, Patricia, Fernández-Zarzoso, Miguel, Marco, Fernando, Vidal Manceñido, Mª Jesús, Smucler Simonovich, Alicia, López Rubio, Montserrat, Jarque, Isidro, Suarez, Alexia, Fernández Álvarez, Rubén, Lancharro Anchel, Aima, Ríos, Eduardo, Losada Castillo, María del Carmen, Pérez Persona, Ernesto, García Muñoz, Ricardo, Ramos, Rafael, Yáñez, Lucrecia, Bello, José Luis, Loriente, Cristina, Acha, Daniel, Villanueva, Miguel

Source: In Clinical Lymphoma, Myeloma and Leukemia December 2021 21(12):e985-e999

Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes

Authors: Stuckey, Ruth, Casado, Luis-Felipe, Colomer, Dolors, Gómez-Casares, María Teresa, Casas, Laura, García-Gutierrez, Valentín, Sastre, José Luis, Ramírez-Payer, Ángel, Vall-Llovera, Ferrán, Goñi, María Ángeles, Xicoy, Blanca, Godoy, Ana Cristina, Núñez, Javier, Mora, Itxaso, Vallansot, Rolando, López-Lorenzo, José Luis, Palomera, Luis, Conesa, Venancio, Noya, María Soledad, Sánchez-Guijo, Fermín, Peña, Ascensión, Bautista, Guiomar, Steegmann, Juan Luis

Source: In The Journal of Molecular Diagnostics October 2020 22(10):1217-1224

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Authors: Ferra, Christelle ^*, Terol, María José ^*, Marquet Palomanes, Juan ^*, Ramírez Payer, Angel ^*, Moreno, Carol ^*, Osorio, Santiago ^*, De la Cruz, Fátima ^*, Garcia-Marco, Jose A., Ortiz, Macarena ^*, Rios Herranz, Eduardo ^*, Magnano, Laura ^*, Iraheta, Sandra ^*, Puerta, Jose Manuel ^*, de la Serna, Javier ^*, Smucler, Alicia ^*, Arguiñano, Jose Maria ^*, Loscertales, Javier ^*, Muiña, Begoña ^*, Fernández, Rubén ^*, García, Tomas ^*, Márquez, José A. ^*, Muntañola Prat, Ana ^*, Perez Persona, Ernesto ^*, Yáñez, Lucrecia ^*, Pérez-Encinas, Manuel ^*, González Díaz, Marcos ^*, Caballero, Gonzalo ^*, Andreu, María Angeles ^*, Andreu, Rafael ^*, Ruiz-Zorrilla, Ana ^*, Moreno, Diana ^*, Baltasar, Patricia ^*

Source: In Blood 15 November 2022 140 Supplement 1:9908-9910

Real-World Data Analysis of the Molecular Response Kinetics within the Two First Years of the RELMC-NOVA Study in Newly Diagnosed Spanish CML-CP Patients Treated with Tirosin Kinasa Inhibitors (TKIs) in First Line

Authors: Casado Montero, Luis Felipe, Garcia-Ormeña, Nuria ^*, Perez Encinas, Manuel ^*, Osorio-Prendes, Santiago ^*, Ferrer Marin, Francisca, Sagüés, Miguel ^*, Garcia-Gutiérrez, Valentín, Marco De Lucas, Fernando ^*, Boque, Concepcion ^*, Noya, Soledad ^*, Gomez Casares, María Teresa ^*, Estrada, Natalia ^*, Goñi, Maria Angeles ^*, Ramírez Payer, Angel ^*, Requena, Maria Jose ^*, Lakhwani, Sunil ^*, Andrade Campos, Marcio Miguel ^*, De las Heras, Natalia ^*, Foncillas, María Ángeles ^*, Steegmann, Juan Luis ^*

Source: In Blood 15 November 2022 140 Supplement 1:3908-3910

Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia

Alternate Title: Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica (Spanish; Castilian)

Authors: García-Marco, José A., Delgado, Julio, Hernández-Rivas, José A., Ramírez Payer, Ángel, Loscertales Pueyo, Javier, Jarque, Isidro, Abrisqueta, Pau, Giraldo, Pilar, Martínez, Rafael, Yáñez, Lucrecia, Terol, M. José, González, Marcos, Bosch, Francesc

Source: In Medicina Clínica (English Edition) 21 April 2017 148(8):381-381

Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica

Alternate Title: Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemia (English)

Authors: García-Marco, José A., Delgado, Julio, Hernández-Rivas, José A., Ramírez Payer, Ángel, Loscertales Pueyo, Javier, Jarque, Isidro, Abrisqueta, Pau, Giraldo, Pilar, Martínez, Rafael, Yáñez, Lucrecia, Terol, Mª José, González, Marcos, Bosch, Francesc

Source: In Medicina Clinica 21 April 2017 148(8):381-381

Análisis de minimización de costes de la leucemia linfocítica crónica en España en la era de las terapias orales dirigidas. (Spanish)

Alternate Title: Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies. (English)

Authors: Montañés, Belén, Casado, Gema, Medina, Ángeles, Nieto, Pablo, Ramírez-Payer, Ángel

Source: Farmacia Hospitalaria (1130-6343); mar/abr2022, Vol. 46 Issue 2, p72-79, 16p

Safety and Survival Outcomes in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-Based or Non-Lenalidomide-Based Treatments in the Real-World MM-034 Study

Authors: Cavo, Michele ^*, Dhanasiri, Sujith ^*, De Stefano, Valerio ^*, Ramírez Payer, Angel ^*, Wiesholzer, Martin ^*, Tromp, Yvonne ^*, Perera, Meegahage Ratnakanthi, Richez-Olivier, Valentine ^*, Gil, Maciej ^*, Bernasconi, David ^*, Gamberi, Barbara ^*

Source: In Blood 15 November 2022 140 Supplement 1:7195-7196

Liver Toxicity As Dose Limiting Toxicity of Bosutinib in Combination with Atezolizumab in Chronic Myeloid Leukemia. Results from the Phase Ib/II Zerolmc Trial

Authors: García Gutiérrez, Valentín, Casado Montero, Luis Felipe, de Paz, Raquel ^*, Gómez-Casares, María Teresa ^*, Ramírez Payer, Angel ^*, Ayala, Rosa ^*, Perez Lopez, Raul ^*, Ferrer Marin, Francisca, Xicoy, Blanca ^*, Steegmann, Juan Luis ^*, Sanchez-Guijo, Fermin ^*, Martínez-López, Joaquín ^*

Source: In Blood 15 November 2022 140 Supplement 1:12206-12207

Safety and Survival Outcomes in the Non-Interventional Post-Authorization Study of Patients Treated with Pomalidomide for Relapsed and Refractory Multiple Myeloma: A Sub-Analysis of Patients with Prior Triple Class Exposure

Authors: Ramasamy, Karthik, Abildgaard, Niels, Vekemans, Marie-Christiane ^*, Gamberi, Barbara ^*, Ramírez Payer, Angel ^*, Millar, Gillian ^*, Ansaloni, Annalisa ^*, Atiba-Davies, Margaret ^*, Bernasconi, David ^*, Plesner, Torben, Dhanasiri, Sujith ^*

Source: In Blood 15 November 2022 140 Supplement 1:10000-10001

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Authors: Mosquera Orgueira, Adrian ^*, Perez Encinas, Manuel ^*, Hernández Sánchez, Alberto ^*, González, Teresa ^*, Arellano-Rodrigo, Eduardo ^*, Martínez Elicegui, Javier Martinez ^*, Villaverde Ramiro, Angela ^*, Raya Sanchez, Jose Maria ^*, Ayala, Rosa ^*, Ferrer Marin, Francisca, Fox, Maria Laura ^*, Velez Tenza, Patricia ^*, Mora Casterá, Elvira ^*, Xicoy, Blanca ^*, Mata Vazquez, Maria Isabel ^*, García Fortes, María ^*, Angona, Anna ^*, Cuevas, Beatriz ^*, Senin, María Alicia ^*, Ramírez Payer, Angel ^*, Ramírez, María José ^*, Perez Lopez, Raul ^*, González de Villambrosia, Sonia ^*, Martínez, Clara ^*, Gómez-Casares, María Teresa ^*, Garcia-Hernandez, Carmen ^*, Gasior Kabat, Mercedes ^*, Bellosillo, Beatriz ^*, Steegmann, Juan Luis, Alvarez-Larran, Alberto ^*, Hernández Rivas, Jesús M, Hernandez Boluda, Juan Carlos ^*

Source: In Blood 15 November 2022 140 Supplement 1:826-827

Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.

Authors: Cejalvo, María José, Bustamante, Gabriela, González, Esther, Vázquez-Álvarez, Judith, García, Ricarda, Ramírez-Payer, Ángel, Pérez-Persona, Ernesto, Abella, Eugenia, Garzón, Sebastián, García, Antoni, Jarque, Isidro, González, Marta Sonia, Sampol, Antonia, Motlló, Cristina, Martí, Josep María, Alcalá, Magdalena, Duro, Rafael, González, Yolanda, Sastre, José Luis, Sarrà, Josep

Source: Annals of Hematology; Jul2021, Vol. 100 Issue 7, p1769-1778, 10p

Subject Terms: MULTIPLE myeloma, OVERALL survival, OLDER patients, TREATMENT effectiveness, LACTATE dehydrogenase, THERAPEUTIC use of antineoplastic agents, RESEARCH, MELPHALAN, DOXORUBICIN, DEXAMETHASONE, RESEARCH methodology, ANTINEOPLASTIC agents, RETROSPECTIVE studies, MEDICAL cooperation, EVALUATION research, COMPARATIVE studies, CYCLOPHOSPHAMIDE, KAPLAN-Meier estimator, PREDNISONE

Further psychometric validation of the GAH scale: Responsiveness and effect size

Authors: Cruz-Jentoft, Alfonso José, González, Bernardo, de la Rubia, Javier, Hernández Rivas, José Ángel, Soler, Juan Alfonso, Fernández Lago, Carlos, Arnao, Mario, Gironella, Mercedes, Pérez Persona, Ernesto, Zudaire, María Teresa, Olivier, Carmen, Altés, Alberto, García Guiñón, Antonio, Nomdedeu, Benet, Arnan, Montserrat, Ramírez Payer, Ángel, Sánchez-Godoy, Pedro, Pajuelo, Nuria, Vilanova, David, Monjil, Diego Fernánez, Bonanad, Santiago

Source: In Journal of Geriatric Oncology May 2017 8(3):211-215

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Authors: Baltasar, Patricia, Terol, María José, Marquet Palomanes, Juan, Ramírez Payer, Angel, Moreno, Carol, Osorio, Santiago, De la Cruz, Fátima, Garcia-Marco, Jose A., Sr., Ortiz, Macarena, Ríos Herranz, Eduardo, Magnano, Laura, Iraheta, Sandra, Puerta, Jose Manuel, de la Serna, Javier, Smucler Simonovich, Alicia, Arguiñano, Jose Maria, Loscertales, Javier, Muiña, Begoña, Fernandez, Ruben, García, Tomas, Márquez, José A., Muntañola Prat, Ana, Pérez Persona, Ernesto, Yáñez, Lucrecia, Pérez-Encinas, Manuel, González Díaz, Marcos, Caballero, Gonzalo, Andreu, María Angeles, Andreu, Rafael, Ruiz-Zorrilla, Ana, Moreno, Diana, Ferrà, Christelle

Source: In Blood 23 November 2021 138 Supplement 1:1561-1561

Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature.

Authors: Lecumberri, Ramón, Krsnik, Isabel, Askari, Elham, Sirvent, Maialen, González-Pérez, Marta S., Escalante, Fernando, Pradillo, Virginia, Tamariz, Luis E., Cánovas, Verónica, Alegre, Adrián, Gironella, Mercedes, González-García, María E., Infante, María S., Lakhwani, Sunil, Martínez-Bilbao, Cristina, Dourdil, Victoria, Ramírez-Payer, Ángel, Sarrá, José, Cibeira, M. Teresa

Source: Amyloid; Sep2020, Vol. 27 Issue 3, p163-167, 5p

Subject Terms: AMYLOIDOSIS, CARDIAC amyloidosis, PROGRESSION-free survival, RETROSPECTIVE studies, DARATUMUMAB

Single-Agent Ibrutinib As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice in Spain

Authors: Abrisqueta Costa, Pau ^*, Loscertales, Javier ^*, Terol, Maria Jose ^*, Ramirez Payer, Angel ^*, Ortiz Pareja, Macarena ^*, Perez, Inmaculada ^*, Cuellar, Carolina ^*, Fernandez De La Mata, Margarita ^*, Rodriguez, Alicia ^*, Lario, Ana ^*, Delgado, Julio, Godoy, Ana Cristina ^*, Arguiñano, Jose M ^*, Berruezo, Maria José ^*, Oliveira, Ana C ^*, Hernandez-Rivas, Jose Angel ^*, García-Malo, María-Dolores ^*, Medina, Angeles ^*, García Martín, Paloma ^*, Osorio-Prendes, Santiago ^*, Baltasar, Patricia ^*, Fernandez, Miguel ^*, Marco, Fernando ^*, Vidal, María-Jesús ^*, Smucler Simonovich, Alicia Susana ^*, Lopez Rubio, Montserrat ^*, Jarque, Isidro ^*, Suárez Cabrera, Alexia ^*, Fernandez, Ruben ^*, Lancharro Anchel, Aima ^*, Rios Herranz, Eduardo ^*, Losada, Carmen ^*, Pérez Persona, Ernesto ^*, Garcia, Ricardo Francisco ^*, Ramos, Rafael ^*, Yáñez, Lucrecia ^*, Bello, Jose Luis ^*, Loriente, Cristina ^*, Villanueva, Miguel ^*

Source: In Blood 5 November 2020 136 Supplement 1:32-33

Ibrutinib in Combination with R-Gemox-D in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase II Clinical Trial of the Geltamo Group

Authors: Rey Búa, Beatriz ^*, Jiménez Ubieto, Ana ^*, Sanchez Blanco, Jose Javier ^*, Abrisqueta, Pau ^*, Gutierrez, Antonio ^*, Ramirez Payer, Angel ^*, Giné, Eva, Cebeiro, Izaskun, Sr. ^*, Terol, Maria Jose ^*, De la Cruz, Fatima ^*, Andreu, Rafael ^*, Sánchez, María José Ramírez ^*, de la Fuente, Adolfo ^*, Viguria, Ma Cruz ^*, Peñarrubia, Maria Jesús ^*, Grande, Carlos ^*, Caballero, Dolores, Martin Garcia-Sancho, Alejandro ^*

Source: In Blood 5 November 2020 136 Supplement 1:16-17

This result is not displayed to guests.
Login for full access.

Safety Profile for Lenalidomide-Based and Non-Lenalidomide-Based First-Line Therapy for Multiple Myeloma in Transplant Ineligible Patients: Real-World Evidence from a European Post-Authorization Safety Study

Authors: Cavo, Michele ^*, De Stefano, Valerio ^*, Ramirez Payer, Angel ^*, Wiesholzer, Martin ^*, Tromp, Yvonne ^*, Vanstraelen, Gaëtan ^*, Schaedlich, Baerbel ^*, Valentine, Richez ^*, Dhanasiri, Sujith ^*, Kueenburg, Elisabeth ^*, Rosettani, Barbara ^*, Martin, Claire ^*, Pozzi, Stefano ^*, Bacon, Pamela ^*, Gamberi, Barbara ^*

Source: In Blood 13 November 2019 134 Supplement 1:5580-5580